Today, as part of the second phase of the Transparency Initiative, the Transparency Task Force released 21 draft proposals about FDA’s disclosure policies. FDA is asking for comments on the proposals for 60 days. After 60 days, FDA will use your input to recommend specific proposals to FDA Commissioner Dr. Margaret Hamburg for implementation.
You can read more about the transparency report FDA is releasing today in a Perspective article in the New England Journal of Medicine online, “Transparency at the U.S. Food and Drug Administration.”
FDA will not necessarily implement each of these ideas. Some of the proposals require extensive resources to implement and some may require changes to regulations or legislation.
You can learn about the various ways to give us feedback here.
Visit the FDA Web site to read the report and comment on the proposals. You can let us know what you think about the proposals and what proposals FDA should prioritize, until July 20, 2010.
Afia Asamoah, Transparency Initiative Coordinator